Clinical Study
Hypertension Control and Cardiometabolic Risk: A Regional Perspective
Table 5
Blood pressure and HbA1c (% ± SD, adjusted for age, gender, and diabetes treatment).
| | Total
() | Northern Europe
() | Southern Europe
() | North America
() | Middle East
() | Asia
() | value |
| | SBP (mmHg) | | | | | | | | | <120 | 6.7 (0.115) | 6.2 (0.202) | 6.4 (0.199) | 6.6 (0.214) | 6.4 (0.725) | 6.8 (0.257) | 0.4127 | | 120–139 | 6.6 (0.047) | 6.4 (0.072) | 6.3 (0.081) | 6.4 (0.113) | 7.3 (0.348) | 6.7 (0.114) | 0.0073 | | 140–159 | 6.8 (0.037) | 6.5 (0.049) | 6.5 (0.062) | 6.6 (0.111) | 7.3 (0.168) | 6.8 (0.102) | <0.0001 | | 160–179 | 6.9 (0.052) | 6.6 (0.063) | 6.7 (0.084) | 6.6 (0.167) | 7.6 (0.187) | 6.9 (0.179) | <0.0001 | | ≥180 | 7.0 (0.084) | 6.7 (0.102) | 6.9 (0.135) | 6.4 (0.402) | 8.0 (0.243) | 6.9 (0.292) | <0.0001 | | value | <0.0001 | 0.0003 | 0.0012 | 0.4751 | 0.6808 | 0.7181 | | | DBP (mmHg) | | | | | | | | | <90 | 6.8 (0.031) | 6.5 (0.043) | 6.4 (0.055) | 6.5 (0.074) | 7.2 (0.172) | 6.8 (0.080) | <0.0001 | | 90–99 | 6.8 (0.045) | 6.5 (0.056) | 6.5 (0.069) | 6.6 (0.175) | 7.6 (0.180) | 6.7 (0.128) | <0.0001 | | 100–109 | 6.9 (0.076) | 6.6 (0.096) | 6.8 (0.111) | 6.4 (0.312) | 8.0 (0.226) | 6.4 (0.243) | <0.0001 | | ≥110 | 6.9 (0.172) | 6.7 (0.211) | 6.6 (0.288) | 7.7 (0.934) | 7.2 (0.489) | 7.2 (0.921) | 0.6603 | | value | 0.0027 | 0.1605 | 0.0136 | 0.3190 | 0.3332 | 0.4885 | | | RR (mmHg) | | | | | | | | | uncontrolled* | 6.8 (0.039) | 6.5 (0.035) | 6.6 (0.046) | 6.6 (0.088) | 7.6 (0.111) | 6.8 (0.082) | <0.0001 | | controlled** | 6.7 (0.030) | 6.3 (0.073) | 6.3 (0.079) | 6.5 (0.104) | 7.1 (0.316) | 6.7 (0.110) | 0.0075 | | value | <0.0001 | 0.0004 | 0.0091 | 0.2444 | 0.3367 | 0.3114 | |
|
|
*SBP/DBP ≥140/90 in non-diabetic and ≥130/80 in diabetic patients, **<140/90 in non-diabetic and <130/80 in diabetic patients.
|
